Abstract
A patient is described who had myeloma of the polymeric IgA variety, together with a striking hyperlipidaemia and xanthomatosis. Investigations into the protein and lipid abnormality failed to demonstrate any mechanism for the hyperlipidaemia. A review of the literature, however, validates this clinical entity and some of the suggested explanations are discussed.
MeSH terms
-
Abdomen
-
Cyclophosphamide / therapeutic use
-
Elbow
-
Humans
-
Hyperlipidemias / complications*
-
Hyperlipidemias / drug therapy
-
Immunoglobulin A
-
Knee
-
Male
-
Middle Aged
-
Multiple Myeloma / complications*
-
Multiple Myeloma / drug therapy
-
Prednisolone / therapeutic use
-
Skin Diseases / complications*
-
Syndrome
-
Thorax
-
Xanthomatosis / complications*
Substances
-
Immunoglobulin A
-
Cyclophosphamide
-
Prednisolone